Variant of multiple sclerosis with dementia and tumefactive demyelinating brain lesions

被引:2
|
作者
Hamed, Sherifa A. [1 ]
机构
[1] Assiut Univ Hosp, Hosp Neurol & Psychiat, Dept Neurol & Psychiat, Assiut 71516, Egypt
关键词
Tumefactive multiple sclerosis; Acute dementia;
D O I
10.12998/wjcc.v3.i6.525
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe an unusual clinical and diagnostic feature of a patient with multiple sclerosis (MS). A 25-yearold woman was admitted to the Neurology department (December 2009) with one month history of rapid cognitive deterioration. She had poor cognition, dysphasia, reduction in visual acuity and temporal pallor of the optic discs. She had prolonged latencies of P100 component of visual evoked potentials (VEPs). Magnetic resonance imaging (MRI)-brain showed multifocal large (>= 3 cm) white-matter hypointense lesions in T1W and hyperintense in T2W and fluid-attenuated inversion recovery images and patchy enhancement. A diagnosis of tumefactive MS was given. She received two consecutive 5-d courses of 1 g daily intravenous methylprednisolone for 2 mo and oral prednisolone in dose of 80 mg twice/ daily in between. At the 3rd month, Mini Mental State Examination and VEPs returned to normal but not the MRI. Patient continued oral steroids after hospital discharge (March 2010) for 9 mo with significant MRI improvement after which tapering of steroids started for a year. The patient refused immunomodulation therapy due to her low socioeconomic status. Neither clinical relapse nor new MRI lesions were observed throughout the next 4 years. In spite of the aggressive course of tumefactive MS variant, good prognosis may be seen in some patients.
引用
收藏
页码:525 / 532
页数:8
相关论文
共 50 条
  • [21] Tumefactive demyelinating lesions
    Dagher, AP
    Smirniotopoulos, J
    NEURORADIOLOGY, 1996, 38 (06) : 560 - 565
  • [22] Intracerebral hemorrhage during treatment with natalizumab in a patient with multiple sclerosis and tumefactive demyelinating lesions
    Stich, Oliver
    Janowitz, Daniel
    Rauer, Sebastian
    MULTIPLE SCLEROSIS, 2008, 14 : S180 - S180
  • [23] Tumefactive demyelinating lesions
    Mitha, A. P.
    Scott, J. N.
    George, D.
    Hanson, A.
    MacRae, M. E.
    Bell, R. B.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2007, 34 (03) : 362 - 364
  • [24] Recovery of tumefactive demyelinating lesions in a multiple sclerosis patient as evidenced by magnetization transfer imaging
    Ikonomidou, Vasiliki N.
    Ohayon, Joan M.
    Cook, Natalie E.
    Richert, Nancy
    Bielekova, Bibiana
    McFarland, Henry
    Bagnato, Francesca
    NEUROLOGY, 2008, 70 (11) : A243 - A243
  • [25] Bilateral tumefactive multiple sclerosis lesions
    Haritanti, A
    Lefkopoulos, A
    Papadopoulou, E
    Kouskouras, C
    Hatzisavvas, N
    Pashalidou, M
    Taskos, N
    Dimitriadis, A
    RIVISTA DI NEURORADIOLOGIA, 2005, 18 (03): : 365 - 370
  • [26] Cerebral tumefactive demyelinating lesions
    Qi, Wei
    Jia, Ge
    Wang, Xinsheng
    Zhang, Maozhi
    Ma, Zhenyu
    ONCOLOGY LETTERS, 2015, 10 (03) : 1763 - 1768
  • [27] Tumefactive Demyelinating Lesions and Pregnancy
    Plantone, Domenico
    Piantadosi, Carlo
    Ruggieri, Serena
    Anelli, Vincenzo
    Koudriavtseva, Tatiana
    NEUROLOGY INDIA, 2019, 67 (06) : 1519 - 1521
  • [28] CHARACTERISATION OF TUMEFACTIVE DEMYELINATING LESIONS
    Fontes-Villalba, Ariadna A.
    French, Heath H.
    Parratt, John D. E.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 (05):
  • [29] Tumefactive demyelinating disease is immunologically different from multiple sclerosis
    Boz, C.
    Gazioglu, S.
    Terzi, M.
    MULTIPLE SCLEROSIS, 2007, 13 : S211 - S211
  • [30] Tumefactive demyelinating lesions in children
    Selek, Ayberk
    Gocmen, Rahsan
    Gunbey, Ceren
    Konuskan, Bahadir
    Oncel, Ibrahim
    Anlar, Banu
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2025, 55 : 33 - 37